kidney disease

HOUSTON, Texas | April 10, 2026 FibroBiologics has unveiled promising preclinical data for its novel thymus organoid platform, demonstrating...

WALTHAM, Massachusetts | April 9, 2026 Swedish Orphan Biovitrum (Sobi) has announced that Health Canada has approved EMPAVELI® (pegcetacoplan),...

Ingelheim, Germany | January 29, 2026 — Boehringer Ingelheim announced positive results from a 12-week Phase II clinical trial...

BAD HOMBURG, Germany, Dec. 10, 2025 — Fresenius Medical Care, the world’s leading provider of products and services for...

September 18, 2025 — Las Vegas, Nevada Avant Technologies and Austrianova have entered into a Joint Venture and Licensing...